Literature DB >> 3545884

Quantification and chemical markers of tobacco-exposure.

J Prignot.   

Abstract

Quantitation of exposure to tobacco products is useful for any individual smoker, and necessary for epidemiological studies which relate smoking to pathology, or which are concerned with the efficacy of smoking cessation methods. The medical history, trying to quantitate the current mean daily cigarette consumption (consumption rate), the cumulative risk (pack years) and the various types of smoking, including inhalation habits, should also be attempted. However, due to the quasi-systematic underrating of tobacco consumption which smokers have revealed on many occasions, together with difficulty in correctly observing cigarette smoking, objective validation of recent historical data by quantitative measurement of tobacco products in tissue fluids is mandatory. Measurements of nicotine and cotinine levels in serum and urine require elaborate and expensive methods, and are not adequate for validation of smoking cessation in smokers who are using nicotine chewing gum. Carbon monoxide is a good marker of smoke inhalation. Normal carboxyhaemoglobin levels allow us to confirm that a subject has recently stopped smoking, as its half-life is only a few hours in blood. Salivary (or plasma) measurements of thiocyanate discriminate between smokers and ex-smokers, with a high probability, particularly in those who have stopped smoking for at least 14 days, separating these clearly from current smokers. However, several potential causes of error must be considered to allow correct interpretation of measurements of thiocyanate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3545884

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  34 in total

1.  Body composition and sarcopenia in patients with chronic obstructive pulmonary disease.

Authors:  Tatiana Munhoz da Rocha Lemos Costa; Fabio Marcelo Costa; Thaísa Hoffman Jonasson; Carolina Aguiar Moreira; César Luiz Boguszewski; Victória Zeghbi Cochenski Borba
Journal:  Endocrine       Date:  2018-02-05       Impact factor: 3.633

2.  Development of reusable logic for determination of statin exposure-time from electronic health records.

Authors:  Aaron W Miller; Catherine A McCarty; Ulrich Broeckel; Vangelis Hytopoulos; Deanna S Cross
Journal:  J Biomed Inform       Date:  2014-03-15       Impact factor: 6.317

3.  The validity of self-reported smoking: a review and meta-analysis.

Authors:  D L Patrick; A Cheadle; D C Thompson; P Diehr; T Koepsell; S Kinne
Journal:  Am J Public Health       Date:  1994-07       Impact factor: 9.308

4.  Contrasting behavioral effects of acute nicotine and chronic smoking in detoxified alcoholics.

Authors:  Jeff Boissoneault; Rebecca Gilbertson; Robert Prather; Sara Jo Nixon
Journal:  Addict Behav       Date:  2011-08-04       Impact factor: 3.913

5.  Association of Angiotensin converting enzyme gene insertion / deletion polymorphism with risk of ischemic heart disease in a population of smokers in southern India.

Authors:  Sandhya Metta; Satyanarayana Uppala; Doddamani R Basalingappa; Srinivasa R Badeti; Geeta Mitta; Shruti Mohanty; Poornima Subhadra; Qurratulain Hasan
Journal:  J Clin Diagn Res       Date:  2015-04-01

6.  Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden.

Authors:  Stephen R Cole; Sonia Napravnik; Michael J Mugavero; Bryan Lau; Joseph J Eron; Michael S Saag
Journal:  Am J Epidemiol       Date:  2009-12-09       Impact factor: 4.897

7.  Correlation between high-resolution computed tomography features and patients' characteristics in chronic obstructive pulmonary disease.

Authors:  Prem P Gupta; Rohtash Yadav; Manish Verma; Dipti Agarwal; Manoj Kumar
Journal:  Ann Thorac Med       Date:  2008-07       Impact factor: 2.219

8.  Evaluation of brain stem auditory evoked potentials in stable patients with chronic obstructive pulmonary disease.

Authors:  Prem Parkash Gupta; Sushma Sood; Atulya Atreja; Dipti Agarwal
Journal:  Ann Thorac Med       Date:  2008-10       Impact factor: 2.219

9.  The urge-to-cough and cough motor response modulation by the central effects of nicotine.

Authors:  Paul W Davenport; Andrea Vovk; Rita K Duke; Donald C Bolser; Erin Robertson
Journal:  Pulm Pharmacol Ther       Date:  2008-12-07       Impact factor: 3.410

10.  Erythrocyte Antioxidant Defenses Against Cigarette Smoking in Ischemic Heart Disease.

Authors:  Sandhya Metta; Doddamani R Basalingappa; Satyanarayana Uppala; Geeta Mitta
Journal:  J Clin Diagn Res       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.